GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (STU:0I3) » Definitions » Other Long Term Assets

Axonics (STU:0I3) Other Long Term Assets : €36.4 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Axonics Other Long Term Assets?

Axonics's other long-term assets for the quarter that ended in Mar. 2024 was €36.4 Mil.

Axonics's quarterly other long-term assets increased from Sep. 2023 (€3.0 Mil) to Dec. 2023 (€33.9 Mil) and increased from Dec. 2023 (€33.9 Mil) to Mar. 2024 (€36.4 Mil).

Axonics's annual other long-term assets declined from Dec. 2021 (€6.8 Mil) to Dec. 2022 (€6.4 Mil) but then increased from Dec. 2022 (€6.4 Mil) to Dec. 2023 (€33.9 Mil).


Axonics Other Long Term Assets Historical Data

The historical data trend for Axonics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Other Long Term Assets Chart

Axonics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial 4.31 6.36 6.84 6.43 33.88

Axonics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.10 2.60 3.04 33.88 36.37

Axonics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Axonics (STU:0I3) Business Description

Traded in Other Exchanges
Address
26 Technology Drive, Irvine, CA, USA, 92618
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.

Axonics (STU:0I3) Headlines

No Headlines